Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Immunoassays: Page 4
Swedish study shows blood test may help in evaluating epilepsy
By
Elissa Wolfson
High levels of immune proteins before and after epileptic seizures may serve as epilepsy biomarkers that can be identified with a simple blood test.
March 14, 2023
QuidelOrtho nabs FDA de novo authorization for COVID-19 lateral flow immunofluorescent assay
By
LabPulse.com staff writers
Sofia 2 SARS Antigen+ FIA is a lateral flow immunofluorescent assay used with the firms Sofia 2 fluorescent immunoassay analyzer.
March 8, 2023
Rowan University, Durin Technologies tout preliminary results for early Alzheimer's blood test
Using eight autoantibody biomarkers, the test identified the presence of Alzheimer's disease pathology across the disease's progression, including among those originally determined to have no trace of the disease, the researchers said.
March 8, 2023
PerkinElmer Q4 revenues drop 28% on COVID headwinds
By
Leo O'Connor
As the firm prepared for the near-term divestiture of its Applied, Food, and Enterprise Services business, it included no contribution from COVID-related revenues in its 2023 forecast.
February 14, 2023
COVID-19 immune response strengthens over time: Study
By
Elissa Wolfson
COVID-19 immunity may gather strength with more time between vaccination and infection; people who’ve had the virus benefit even from delayed vaccination, according to a study published in Journal for Clinical Investigation Insight.
January 27, 2023
FDA grants authorizations for two over-the-counter COVID-19 tests
By
LabPulse.com staff writers
As of last week, 440 tests and sample collection devices had received FDA EUAs. They include 297 molecular tests and sample collection devices, 85 antibody and other immune response tests, 57 antigen tests, and one diagnostic breath test.
December 27, 2022
Neuroscientists report preliminary validation of Alzheimer’s blood biomarker
By
Elissa Wolfson
Brain derived-tau levels detected in Alzheimer’s patients’ blood samples using a new assay matched with tau levels in CSF, reliably distinguishing Alzheimer’s from other diseases.
December 28, 2022
Marketing tool enables sales of more than $1M Jiqing Biotech COVID-19 kits per day in China
By
LabPulse.com staff writers
Sales have been enabled by WeTrade's multidimensional SaaS-based marketing tool, the firm said.
December 22, 2022
Tulsa ER & Hospital adopts MeMed host-response test to quickly distinguish between bacterial and viral infections
By
LabPulse.com staff writers
Israel-based MeMed said it leverages machine learning to translate the complex signaling of the immune system into diagnostic insights.
December 22, 2022
QuidelOrtho nabs Health Canada approval for high-sensitivity troponin I test on small-footprint analyzer
By
LabPulse.com staff writers
The test, a fluorescence immunoassay, runs on the Quidel Triage MeterPro platform and provides a quantitative determination of troponin I in whole blood or plasma specimens as an aid in the diagnosis of myocardial infarction.
December 20, 2022
Test choices for COVID-19, flu confusing for many: new survey
By
LabPulse.com staff writers
The survey findings are compelling in the context of a potential tripledemic, as influenza, COVID-19, and respiratory syncytial virus cases rise.
December 16, 2022
Exposure to SARS-CoV-2 vaccination and infection may provide more durable immunity: Canadian study
By
Jared Berberabe
Exposure to vaccination and infection "likely provides stronger, broader, and more durable hybrid immunity than either exposure alone, especially against severe outcomes,” the researchers said.
December 6, 2022
Previous Page
Page 4 of 61
Next Page